New male birth control pill enters human testing
NCT ID NCT07195097
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether a drug called silodosin can work as a temporary, nonhormonal birth control pill for men. Two hundred healthy, sexually active men will take either the drug or a placebo for up to 12 weeks. Researchers will measure sperm counts, semen volume, and pregnancy rates in their partners to see if the pill is effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRACEPTION USE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.